Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Radcliff, Tiffany A.
Lorden, Andrea L.
and
Zhao, Hongwei
2016.
Clostridium difficile Infection in Texas Hospitals, 2007-2011.
Infection Control & Hospital Epidemiology,
Vol. 37,
Issue. 3,
p.
357.
Schulz-Stübner, Sebastian
Textor, Zoran
and
Anetseder, Martin
2016.
Fecal Microbiota Therapy as Rescue Therapy for Life-Threatening Clostridium difficile Infection in the Critically Ill: A Small Case Series.
Infection Control & Hospital Epidemiology,
Vol. 37,
Issue. 9,
p.
1129.
Drees, Marci
Gerber, Jeffrey S.
Morgan, Daniel J.
and
Lee, Grace M.
2016.
Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship: Use of Administrative and Surveillance Databases.
Infection Control & Hospital Epidemiology,
Vol. 37,
Issue. 11,
p.
1278.
Winston, Jenessa A.
and
Theriot, Casey M.
2016.
Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract.
Anaerobe,
Vol. 41,
Issue. ,
p.
44.
Doufair, Mouna
Eckert, Catherine
Drieux, Laurence
Amani-Moibeni, Come
Bodin, Liliane
Denis, Michel
Grange, Jean Didier
Arlet, Guillaume
and
Barbut, Frédéric
2017.
Clostridium difficile bacteremia: Report of two cases in French hospitals and comprehensive review of the literature.
IDCases,
Vol. 8,
Issue. ,
p.
54.
Guidry, Christopher A.
Hranjec, Tjasa
Shah, Puja M.
Dietch, Zachary C.
Hassinger, Taryn E.
Elwood, Nathan R.
and
Sawyer, Robert G.
2017.
Aggressive Antimicrobial Initiation for Suspected Intensive Care Unit-Acquired Infection Is Associated with Decreased Long-Term Survival after Critical Illness.
Surgical Infections,
Vol. 18,
Issue. 6,
p.
664.
Guidry, Christopher A.
and
Sawyer, Robert G.
2017.
Prevalence of Recent Antimicrobial Exposure among Elective Surgical Patients.
Surgical Infections,
Vol. 18,
Issue. 7,
p.
799.
Schulz-Stübner, S.
2017.
Repetitorium Krankenhaushygiene, hygienebeauftragter Arzt und ABS-beauftragter Arzt.
p.
299.
Ship, Noam
and
Carrière, Serge
2018.
Going back to prospectively collected results with a probiotic for primary prevention of Clostridium difficile infection at a tertiary-care medical center.
Infection Control & Hospital Epidemiology,
Vol. 39,
Issue. 11,
p.
1392.
Tariq, Raseen
Cho, Janice
Kapoor, Saloni
Orenstein, Robert
Singh, Siddharth
Pardi, Darrell S
and
Khanna, Sahil
2018.
Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis.
Clinical Infectious Diseases,
Vol. 66,
Issue. 4,
p.
514.
Edmiston, Charles E.
Garcia, Robert
Barnden, Marsha
DeBaun, Barbara
and
Johnson, Helen Boehm
2018.
Rapid diagnostics for bloodstream infections: A primer for infection preventionists.
American Journal of Infection Control,
Vol. 46,
Issue. 9,
p.
1060.
Poole, Nicole M.
2018.
Judicious antibiotic prescribing in ambulatory pediatrics: Communication is key.
Current Problems in Pediatric and Adolescent Health Care,
Vol. 48,
Issue. 11,
p.
306.
Guidry, Christopher A.
Shah, Puja M.
Dietch, Zachary C.
Elwood, Nathan R.
Krebs, Elizabeth D.
Mehaffey, J. Hunter
and
Sawyer, Robert G.
2018.
Recent Anti-Microbial Exposure Is Associated with More Complications after Elective Surgery.
Surgical Infections,
Vol. 19,
Issue. 5,
p.
473.
Wijarnpreecha, Karn
Panjawatanan, Panadeekarn
Thongprayoon, Charat
and
Ungprasert, Patompong
2019.
Statins & risk of Clostridium difficile infection: A meta-analysis.
Indian Journal of Medical Research,
Vol. 150,
Issue. 4,
p.
359.
Moura, Ines B.
Buckley, Anthony M.
Ewin, Duncan
Shearman, Sharie
Clark, Emma
Wilcox, Mark H.
and
Chilton, Caroline H.
2019.
Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human Colon.
Antimicrobial Agents and Chemotherapy,
Vol. 63,
Issue. 2,
Tabak, Ying P.
Srinivasan, Arjun
Yu, Kalvin C.
Kurtz, Stephen G.
Gupta, Vikas
Gelone, Steven
Scoble, Patrick J.
and
McDonald, L. Clifford
2019.
Hospital-level high-risk antibiotic use in relation to hospital-associated Clostridioides difficile infections: Retrospective analysis of 2016–2017 data from US hospitals.
Infection Control & Hospital Epidemiology,
Vol. 40,
Issue. 11,
p.
1229.
Balsells, Evelyn
Shi, Ting
Leese, Callum
Lyell, Iona
Burrows, John
Wiuff, Camilla
Campbell, Harry
Kyaw, Moe H
and
Nair, Harish
2019.
Global burden of Clostridium difficile infections: a systematic review and meta-analysis.
Journal of Global Health,
Vol. 9,
Issue. 1,
Winston, Jenessa A.
Rivera, Alissa J.
Cai, Jingwei
Thanissery, Rajani
Montgomery, Stephanie A.
Patterson, Andrew D.
Theriot, Casey M.
and
Raffatellu, Manuela
2020.
Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
Infection and Immunity,
Vol. 88,
Issue. 6,
Gaviola, Marian L.
Scribe, Emily C.
Leverett, Haley N.
and
Howard, Meredith L.
2020.
Statin Effects on Incidence, Treatment Success, and Mortality of Clostridium difficile Infections.
Journal of Pharmacy Practice,
Vol. 33,
Issue. 4,
p.
497.
Engevik, Melinda A.
Danhof, Heather A.
Shrestha, Ritu
Chang-Graham, Alexandra L.
Hyser, Joseph M.
Haag, Anthony M.
Mohammad, Mahmoud A.
Britton, Robert A.
Versalovic, James
Sorg, Joseph A.
and
Spinler, Jennifer K.
2020.
Reuterin disrupts Clostridioides difficile metabolism and pathogenicity through reactive oxygen species generation.
Gut Microbes,
Vol. 12,
Issue. 1,
p.
1795388.